Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT. (Q54367385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

X-S Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

S Jin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

H-H Zhu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

L-P Xu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

D-H Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

H Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

K-Y Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

6 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

499-507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21643023%20AND%20SRC:MED&resulttype=core&format=json

WT1 gene transcript assay for relapse in acute leukemia after transplantation

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

WT1 monitoring in core binding factor AML: comparison with specific chimeric products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

7 January 2021

Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

7 January 2021

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

7 January 2021

Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.121

7 January 2021